Page 162 - Read Online

Kumar et al. Cancer Drug Resist 2019;2:161-77 I http://dx.doi.org/10.20517/cdr.2018.27 Page 177

138. Gouaze-Andersson V, Yu JY, Kreitenberg AJ, Bielawska A, Giuliano AE, et al. Ceramide and glucosylceramide upregulate expression
of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta 2007;1771:1407-17.
139. Akao Y, Banno Y, Nakagawa Y, Hasegawa N, Kim TJ, et al. High expression of sphingosine kinase 1 and S1P receptors in
chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem Biophys Res Commun
2006;342:1284-90.
140. Alexander S, Min J, Alexander H. Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for
sphingolipids in chemoresistance. Biochim Biophys Acta 2006;1760:301-9.
141. Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, et al. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the
regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem 2007;282:10922-34.
142. Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, et al. miRNA-95 mediates radioresistance in tumors by targeting the
sphingolipid phosphatase SGPP1. Cancer Res 2013;73:6972-86.